Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Volatile Times and Short Term Position Trading 3x ETFs. -- Ignore unavailable to you. Want to Upgrade?

To: Doug R who wrote (74)	3/2/2020 9:21:38 AM
From: Doug R	1 Recommendation Recommended By Hawkmoon Read Replies (1) \| Respond to of 4366

Yeah...ok...now what...lol. GTT Communications (GTT) came out with a quarterly loss of $0.21 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this telecommunications services provider would post a loss of $0.20 per share when it actually produced a loss of $0.31, delivering a surprise of -55%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. GTT Communications, which belongs to the Zacks Computers - IT Services industry, posted revenues of $423.90 million for the quarter ended December 2019, surpassing the Zacks Consensus Estimate by 0.04%. This compares to year-ago revenues of $454.80 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. GTT Communications shares have added about 33.4% since the beginning of the year versus the S&P 500's decline of -8.6%. What's Next for GTT Communications? While GTT Communications has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

To: Doug R who wrote (74)	3/2/2020 10:32:14 PM
From: Doug R	Read Replies (1) \| Respond to of 4366

Other than those mentioned, and now the 3 "problem children" among them appropriately dealt with, ADVM, CLSD, DRRX, NK, SAVA, RAD, ONCY, MBOT and CDTX remain with CALA and several other smaller positions....from the remaining GTT on down to GSM. NH and IBIO were new additions. All symbols above, are in a trading portfolio and as such are all destined to be sold at some point anyway. There are many biotechs that found their way to the 56er thread in the last couple months. Other than that commonality in the symbols above, many are also 38 specials. Bear ETFs started the day at 25% of portfolio after Friday trimming so the day was balanced at 75% short vs 75% long. Long gains outperformed short losses - up 2.2% net. (GTT was NOT helpful at all) Tomorrow will be for rebalancing back toward the short side.